Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Ampicillin Sodium: Precision β-Lactam for Antibacterial R...

    2025-10-31

    Ampicillin Sodium: Precision β-Lactam for Antibacterial Research

    Principle and Scientific Rationale

    Ampicillin sodium (CAS 69-52-3) is a high-purity β-lactam antibiotic that remains indispensable in both foundational and translational bioscience research. Its mechanism centers on competitive inhibition of bacterial transpeptidase enzymes—disrupting the final stages of bacterial cell wall biosynthesis and triggering cell lysis. This molecular action is highly effective against a broad spectrum of Gram-positive and Gram-negative bacteria, making Ampicillin sodium a go-to tool for antibacterial activity assays, protein expression, and antibiotic resistance studies.

    With an IC50 of 1.8 μg/ml against transpeptidase in E. coli 146 cells and a minimum inhibitory concentration (MIC) of 3.1 μg/ml, Ampicillin sodium delivers robust, quantifiable inhibition. Its water solubility (≥18.57 mg/mL) and compatibility with DMSO and ethanol facilitate easy integration into diverse experimental designs. The compound’s high purity (98%, backed by NMR, MS, and COA) ensures reproducibility—critical for sensitive workflows such as those in structural biology or antibiotic resistance profiling.

    Step-by-Step Workflow: Enhanced Protocols for Recombinant Protein Expression and Antibacterial Assays

    1. Selective Pressure in Recombinant Protein Purification

    One of the most widely adopted applications of Ampicillin sodium is in the selection and maintenance of plasmid-bearing bacterial strains for recombinant protein production. For example, the landmark study by Burger et al. (DOI: 10.1016/0014-5793(93)80185-W) details the use of 50 μg/mL Ampicillin in E. coli W3110 cultures expressing recombinant annexin V. This antibiotic pressure ensures that only transformed bacteria grow, minimizing background and streamlining downstream purification.

    • Preparation: Dissolve Ampicillin sodium freshly in sterile water to a 100 mg/mL stock. Filter sterilize and store aliquots at -20°C. Avoid repeated freeze/thaw cycles.
    • Application: Supplement LB or other growth media with 50–100 μg/mL Ampicillin sodium. For high-copy or leaky-expression plasmids, monitor for satellite colony formation, indicating possible antibiotic degradation.
    • Harvest: Grow cultures to OD600 1.5–2.0, induce protein expression (e.g., with 1 mM IPTG), and proceed to cell lysis and purification.

    2. Antibacterial Activity Assays and Bacterial Cell Wall Biosynthesis Inhibition

    Ampicillin sodium’s precise competitive inhibition of transpeptidase enzymes enables rigorous antibacterial activity assays. By quantifying MIC and IC50 values, researchers can benchmark compound potency, screen for resistance phenotypes, and profile Gram-positive and Gram-negative bacterial responses.

    • Setup: Prepare serial dilutions of Ampicillin sodium in assay buffer. Inoculate bacterial cultures (e.g., E. coli 146) to defined cell densities.
    • Readout: Monitor growth inhibition spectrophotometrically (OD600) or via colony-forming units (CFU) enumeration over 16–24 hours.
    • Interpretation: Compare observed MIC/IC50 data to benchmark values (e.g., MIC of 3.1 μg/mL) to assess strain susceptibility or resistance.

    Advanced Applications and Comparative Advantages

    Optimizing Protein Expression and Purification

    In workflows requiring high-purity recombinant protein—such as X-ray crystallography, electron microscopy, or patch-clamp electrophysiology—using a well-characterized antibiotic like Ampicillin sodium is essential. The reference annexin V purification (Burger et al.) demonstrates how precise antibiotic selection prevents plasmid loss and maintains homogeneity throughout growth and induction phases, directly impacting yield and downstream biophysical analysis.

    Antibiotic Resistance Research

    Ampicillin sodium is a frontline tool for studying mechanisms of β-lactam resistance, including β-lactamase activity and altered transpeptidase targets. Integrating it into antibacterial activity assay panels or bacterial infection models enables real-time tracking of resistance emergence and supports the development of next-generation β-lactam derivatives.

    Comparative Insights: Complementary and Extended Uses

    Troubleshooting and Optimization Tips

    • Satellite Colonies: If satellite colonies appear on selection plates, it may indicate hydrolysis of Ampicillin sodium by β-lactamases. Use freshly prepared plates and monitor storage conditions. Consider higher concentrations or alternative antibiotics for high-copy plasmids or extended incubations.
    • Solution Stability: Ampicillin sodium solutions are prone to degradation—always prepare stocks fresh, store at -20°C, and avoid long-term or repeated freeze/thaw cycles. For sensitive assays, verify antibiotic activity via control cultures before use.
    • Consistency in Antibacterial Assays: Standardize inoculum size, media composition, and incubation parameters. Variability in these factors can confound IC50 and MIC readouts.
    • Gram-Negative vs. Gram-Positive Outcomes: Recognize that outer membrane permeability and β-lactamase expression differ among species. Adjust antibiotic concentrations accordingly and use control strains to validate assay integrity.
    • Quality Control: Leverage Ampicillin sodium’s 98% purity and QC documentation for regulatory compliance or publication-ready data. For biophysical workflows, ensure that no antibiotic carry-over interferes with downstream applications such as crystallization.

    Future Outlook: Ampicillin Sodium in Next-Generation Research

    As antibiotic resistance continues to escalate globally, precise tools like Ampicillin sodium are critical for innovating new antibacterial strategies and understanding resistance mechanisms. Its proven efficacy, well-characterized action as a competitive transpeptidase inhibitor, and broad applicability in both in vitro and animal infection models position it as a cornerstone for future research in bacterial cell wall biosynthesis inhibition and translational drug development.

    Emerging applications include high-throughput screening of resistance mutants, integration into synthetic biology platforms, and deployment in combination therapies to dissect synergistic mechanisms. Ongoing refinements in assay design, as highlighted in recent reviews (see mechanism & research overview), will further enhance the utility of Ampicillin sodium in the fight against Gram-positive and Gram-negative bacterial infections.

    Explore the full potential of Ampicillin sodium (SKU: A2510) and integrate this gold-standard β-lactam antibiotic into your next research breakthrough.